PF-07264660
- Generic Name
- PF-07264660
A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants
- First Posted Date
- 2024-12-02
- Last Posted Date
- 2025-04-20
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT06712082
- Locations
- 🇨🇳
Huashan Hospital,Fudan University, Shanghai, Shanghai, China
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
Phase 2
Recruiting
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2023-08-16
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 340
- Registration Number
- NCT05995964
- Locations
- 🇺🇸
Allervie Clinical Research, Birmingham, Alabama, United States
🇺🇸Medical Dermatology Specialists, Phoenix, Arizona, United States
🇺🇸Banner - University Medicine Dermatology Clinic, Tucson, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath